Integrated clinical experience with tolerogenic peptides

International Archives of Allergy and Immunology

Volumn 113, Issue 1-3, 1997, Pages 326-328

  Nicodemus, Christopher ^a,b   Philip, George ^a,b   Jones, Nancy ^a,b   Hirani, Shirish ^a,b   Norman, Philip ^a,b  

^a ImmuLogic Pharmaceutical Corporation   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Allervax ; Cat allergy; Peptide; T cell tolerance

Indexed keywords

ALLERGEN; ALLERVAX; RAGWEED ANTIGEN; UNCLASSIFIED DRUG;

ALLERGY; CONFERENCE PAPER; EUROPE; HUMAN; JAPAN; NORTH AMERICA; PRIORITY JOURNAL;

ALLERGENS; ANIMALS; CATS; GLYCOPROTEINS; HISTAMINE ANTAGONISTS; HUMANS; HYPERSENSITIVITY; T-LYMPHOCYTES;

EID: 0030932299     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237590     Document Type: Article

References (7)

1. Wallncr BP, Gefter ML: Immunotherapy with T-cell-reactive peptides derived from allergen, Allergy 1994;49:302-308.
2. Nicodemus CF: Tolerogenic peptides; in Austen KF, Burakoff S, Rosen F, Strom-T (eds): Therapeutic Immunology, Boston, Blackwell, 1996. pp 628-635.
3. Creticos PS, Spector SL, Busse WW, Israel E, Nicodcmus CF, Joncs NH, Olson T, Gefter ML, Lichtenstein LM, Norman PS: Evaluation of T cell epitope defined peptides from cat allergen by bronchial challenge, J Allergy Clin Immunol 1995:95:390.
4. Norman PS, Ohman JL, Long AA, Creticos PS, Gefter ML, Shakcd Z, Wood RA, Eggleston PA, Lichtenstein LM, Jones NH, Nicodemus CF: Follow on study of the first clinical trial with T cell defined peptides from cat allergen Fel d 1. J Allergy Clin Immunol 1995;95:25.
5. Norman PS, Ohman JL, Long AA, Creticos PS, Gefter MA, Shaked Z, Wood RA, Eggleston PA, Hafner KB, Rao P, Lichtenstein LM, Jones NH, Nicodemus CF: Treatment of cat allergy with T cell reactive peptides, Am J Respir Crit Care Med 1996:154:1623-1628.
6. Lichtenstein LM, Creticos PS, Norman PS, Jones NH, Settles M, Wallner B, Nicodemus CF: Initial clinical experience with T cell epitope defined peptides from ragweed allergen, J Allergy Clin Immunol 1995:95:390.
7. Creticos P, Hebert J, Philip G, Allervaxand Ragweed Study Group: Efficacy of Allervax ragweed peptides in the treatment of ragweed-induced allergy, J Allergy Clin Immunol 1997;(abstract in press)